Semaglutide (Wegovy, Ozempic) received FDA approval for chronic weight management in 2021, followed by tirzepatide (Zepbound) in 2023, both demonstrating substantial weight loss in clinical trials
Of course, as with any weight-loss procedure, surgical weight loss requires focus and dedication to the patients long-term lifestyle change, including improved diet and exercise
For CY 2024, we estimate the share of ASC utilization of CPT code 66984 increased and was reported 81.5 percent of the time in an ASC setting while it declined to 9.2 percent of the time in the HOPD setting
Receives 20,000-Unit Production Run of BPC-157 Transdermal Patches July 14, 2026 The Precision Peptide Company Provides MMA.INC Partnership Update Ahead of Conor McGregors UFC 329 Return July 8, 2026 The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch July 7, 2026 The Precision Peptide Companys Needle-Free Recovery Patch Featured in Mens Health Magazine June 30, 2026 The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification June 23, 2026 The Precision Peptide Company Announces Release of The Human Upgrade with Dave Asprey Episode Featuring Chief Scientific Officer Justin Kirkland June 16, 2026 The Precision Peptide Company Inc
WBCIL is an innovative manufacturer of liposomal phospholipid-based excipients and is exploring potential therapeutic benefits of liposomal excipients
Nicolau J, Tamayo MI, Sanchis P, et al